Do you add ADT to RT for a patient with intermediate-risk prostate cancer with discordant Decipher and ArteraAI results?

For example, if a patient with intermediate risk prostate cancer has a high risk Decipher score (10 year risk of metastasis with standard therapy of >15%), but is low risk by ArteraAI and is biomarker negative, would you add ADT to RT?

Community PollStarted

Which of these tests are routinely utilized in your practice for prostate cancer?

290 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer

Mednet MemberInvited Expert

Radiation Oncology · Case Western Reserve University/ University Hospitals Seidman Cancer Center

Answered on

This will be a long response to try to provide transparency to these tests from what I know as a researcher and clinician. I also clinically see this situation frequently. We have made incredible progress in developing biomarkers in prostate cancer, but it is important to know that no single test is...

Join for free or sign in to see the full answer